1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol
C65H67F3N10O2 — CID 158040892
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol
1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol (PubChem CID 158040892) has the molecular formula C65H67F3N10O2 and a molecular weight of 1077.31 g/mol. Its IUPAC name is 1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol.
Molecular Properties
| Compound Name | 1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol |
|---|---|
| PubChem CID | 158040892 |
| Molecular Formula | C65H67F3N10O2 |
| Molecular Weight | 1077.31 g/mol |
| Exact Mass | 1076.54 |
| IUPAC Name | 1-[(4-tert-butylphenyl)methyl]-5-(1H-pyrazol-4-yl)-2,3-dihydroindole;5-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]pyrrolidin-2-one;1,1,1-trifluoro-2-[4-[[5-(1H-pyrazol-4-yl)-2,3-dihydroindol-1-yl]methyl]phenyl]propan-2-ol |
| SMILES | CC(C)(C)c1ccc(CN2CCc3cc(-c4cn[nH]c4)ccc32)cc1.CC(O)(c1ccc(CN2CCc3cc(-c4cn[nH]c4)ccc32)cc1)C(F)(F)F.O=C1CCC(c2ccc(CN3CCc4cc(-c5cn[nH]c5)ccc43)cc2)N1 |
| InChI | InChI=1S/C22H22N4O.C22H25N3.C21H20F3N3O/c27-22-8-6-20(25-22)16-3-1-15(2-4-16)14-26-10-9-18-11-17(5-7-21(18)26)19-12-23-24-13-19;1-22(2,3)20-7-4-16(5-8-20)15-25-11-10-18-12-17(6-9-21(18)25)19-13-23-24-14-19;1-20(28,21(22,23)24)18-5-2-14(3-6-18)13-27-9-8-16-10-15(4-7-19(16)27)17-11-25-26-12-17/h1-5,7,11-13,20H,6,8-10,14H2,(H,23,24)(H,25,27);4-9,12-14H,10-11,15H2,1-3H3,(H,23,24);2-7,10-12,28H,8-9,13H2,1H3,(H,25,26) |
| InChIKey | FIILXQWIEVZVGZ-UHFFFAOYSA-N |
| XLogP | 12.94 |
| TPSA | 145.09 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 80 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1077.31 |
| LogP ≤ 5 | 12.94 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158040892 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.